Sanil Bhatia

Duesseldorf, NW 40225, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 60 publications

Targeting Histone Acetyltransferases EP300/CBP by Novel Proline-Based PROTAC Degraders.

Targeting Histone Acetyltransferases EP300/CBP by Novel Proline-Based PROTAC Degraders.

Journal: ACS medicinal chemistry letters
Published: March 18, 2026

Measurable Residual Disease-Dependent Unfavorable Outcomes in Pediatric PAX5-Rearranged B-Acute Lymphoblastic Leukemia.

Measurable Residual Disease-Dependent Unfavorable Outcomes in Pediatric PAX5-Rearranged B-Acute Lymphoblastic Leukemia.

Journal: Blood
Published: February 13, 2026

Discovery of Histone Deacetylase 8-Specific Proteolysis-Targeting Chimeras with Anticancer Activity against Hematological Malignancies.

Discovery of Histone Deacetylase 8-Specific Proteolysis-Targeting Chimeras with Anticancer Activity against Hematological Malignancies.

Journal: Journal of medicinal chemistry
Published: January 02, 2026

Epigenetic remodeling via HDAC6 inhibition amplifies anti-tumoral immune responses in myeloid leukemia cells.

Epigenetic remodeling via HDAC6 inhibition amplifies anti-tumoral immune responses in myeloid leukemia cells.

Journal: Cell death & disease
Published: August 03, 2025

Identification of non-charged 7.44 analogs interacting with the NHR2 domain of RUNX1-ETO with improved antiproliferative effect in RUNX-ETO positive cells.

Identification of non-charged 7.44 analogs interacting with the NHR2 domain of RUNX1-ETO with improved antiproliferative effect in RUNX-ETO positive cells.

Journal: Scientific reports
Published: January 31, 2025

Small-molecule inhibitor of C‑terminal HSP90 dimerization modulates autophagy and functions synergistically with mTOR inhibition to kill cisplatin-resistant cancer cells.

Small-molecule inhibitor of C‑terminal HSP90 dimerization modulates autophagy and functions synergistically with mTOR inhibition to kill cisplatin-resistant cancer cells.

Journal: Cell death & disease
Published: January 12, 2025

Pharmacological Inhibition of MDM2 Induces Apoptosis in p53-Mutated Triple-Negative Breast Cancer.

Pharmacological Inhibition of MDM2 Induces Apoptosis in p53-Mutated Triple-Negative Breast Cancer.

Journal: International journal of molecular sciences
Published: December 01, 2024

The protein deacetylase HDAC10 controls DNA replication in malignant lymphoid cells.

The protein deacetylase HDAC10 controls DNA replication in malignant lymphoid cells.

Journal: Leukemia
Published: November 29, 2024

Deciphering the Therapeutic Potential of Novel Pentyloxyamide-Based Class I, IIb HDAC Inhibitors against Therapy-Resistant Leukemia.

Deciphering the Therapeutic Potential of Novel Pentyloxyamide-Based Class I, IIb HDAC Inhibitors against Therapy-Resistant Leukemia.

Journal: Journal of medicinal chemistry
Published: November 27, 2024

H1-0 is a specific mediator of the repressive ETV6::RUNX1 transcriptional landscape in preleukemia and B cell acute lymphoblastic leukemia.

H1-0 is a specific mediator of the repressive ETV6::RUNX1 transcriptional landscape in preleukemia and B cell acute lymphoblastic leukemia.

Journal: HemaSphere
Published: July 04, 2024

Immune training enhances anti-viral responses and improves outcomes in Pax5-/+ mice susceptible to chronic infection.

Immune training enhances anti-viral responses and improves outcomes in Pax5-/+ mice susceptible to chronic infection.

Journal: EMBO molecular medicine
Published: May 31, 2024

Biallelic PI4KA Mutations Disrupt B-Cell Metabolism and Cause B-Cell Lymphopenia and Hypogammaglobulinemia.

Biallelic PI4KA Mutations Disrupt B-Cell Metabolism and Cause B-Cell Lymphopenia and Hypogammaglobulinemia.

Journal: Journal of clinical immunology
Published: April 30, 2024
Showing 1-12 of 60

Last Updated: 09/26/2026